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1. Introduction
  Cervical cancer is the third commonest cancer in women, 
and the seventh overall, with an estimated 530 000 new 
cases in 2008. More than 85% of the global burden occurs 
in developing countries, where it accounts for 13% of all 
female cancers. High-risk regions are Eastern and Western 
Africa (ASR greater then 30 per 100 000), Southern Africa 
(26.8 per 100 000), South-Central Asia (24.6 per 100 000), 
South America and Middle Africa (ASRs 23.9 and 23.0 per 
100 000, respectively). Rates are lowest in Western Asia, 
Northern America and Australia/New Zealand (ASRs less 
than 6 per 100 00)[1]. The different incidence in different 
areas indicates the genetic factors and environmental 
factors play a role in the development of cervical cancer.
  It is well established that human papilloma virus (HPV) 
infection is a necessary but insufficient event for the 
development of cervical cancer[2-5], because not all HPV-
infected patients do develop cervical cancer. Therefore, 
there are other cofactors for cervical cancer development. 
Previous studies showed the glutathione S-transferases 
(GSTs) genetic variants is related to the risk of several 
cancers, including breast, lung, prostate, bladder and 
nasopharyngeal cancer risk[6-8]. There is large number of 
epidemiological studies concerning the association between 
GSTM1 and risk of cervical cancer in different populations, 
however, the results is inconsistent[9-12]. Although there 
is meta-analysis regarding on the two gene polymorphism 
and cervical cancer, no gene-environment interaction was 
explored, especially for Asian population. Therefore, we 
conducted a meta-analysis regarding the effect of GSTM1 
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gene polymorphism on cervical cancer risk, and also explore 
the gene-environment interaction on cervical cancer risk.
 
2. Materials and methods
2.1. Selection criteria and search strategy
  Identification of relevant studies was carried out through 
a search of Medline and EMbase up to May 2011 using the 
following terms without any restriction on language: 
1)cervical$. ab, ti; 2) (carcino$ or cancer$ or neoplasm$ or 
tumour$ or tumor$). ab, ti; 3) adenocarcinoma$. ab, ti; 4) 
or/2-3; 5) 1 and 4; 6) (glutathione S-transferase or GST or 
GSTM or GSTM1). ab, ti; 7)5 and 6.
  The literature search was performed up to December 
2011. The inclusion criteria were as following: case-control 
studies that investigated the association between GSTM1 
polymorphism and risk of cervical cancer; Studies presented 
original data and the number of null genotype of GSTM1 in 
cases and controls. For each study, the following information 
were excluded: name of the first author, publication year, 
ethnicity(county), number of cases and controls; number of 
null genotype for GSTM1 in cases and controls. Two authors 
independently assessed the articles for inclusion/exclusion, 
resolved disagreements, and reached consistency.
2.2. Statistical analysis
  The association between GSTM1 polymorphism and cervical 
cancer was estimated by calculating pooled ORs and 95% 
CIs. The significant of the pooled OR was estimated by Z 
test (P<0.05 was considered statistically significant). The I2-
based Q statistic test was performed to evaluate variations 
due to heterogeneity rather than chance. A random-effects 
or fixed effects methods[13,14] model was used to calculate 
pooled effect estimates in the presence (P≦0.1) or absence 
(P>0.1) of heterogeneity. Begg's funnel plot, a scatter plot 
of effect against a measure of study size, was generated as a 
visual aid to detecting bias or systematic heterogeneity[15]. 
As asymmetric funnel plot indicated a relationship between 
effect and study size, which suggested the possibility of 
either publication bias or a systematic difference between 
smaller and larger studies (small study effects). Furthermore, 
publication bias was assessed by Egger's test[16]. Studies 
were categorized into subgroups based on ethnicity and 
smoking status. The data analysis was performed (STATA, 
version 10, StataCorp LP, College Station, TX).
 
3. Results
  The literature search identified 132 potentially relevant 
studies. Of the 132 literatures, 104 literuatures were 
irrelevant, and 5 studies were excluded because of various 
reasons (2 study was conducted on overlapping population, 
and 3 studies did not include controls in analysis). Finally, 
15 literatures met the inclusion criteria and were included. 
15 case-control studies were included in the meta-analysis 
of GSTM1 genotypes (1 825 cases and 2 104 controls). For the 
meta-analysis of GSTM1, 2 studies on China, 4 studies on 
India, 3 studies on Japan, 2 studies on Korea, 2 studies on 
Italy, one study in America and Thailand. There were 994 
cases of null genotype and 934 controls of null genotype, 
with adjusted OR as 1.14(0.95-1.32). Study characteristics 
included in the meta-analysis are presented in Table 1, and 
P for heterogeneity was <0.05.
  The forest plot of the meta-analysis of GSTM1 is shown 
Table 1
Characteristics of studies included in the meta-analysis. 
ID Ethnicity Study design
Mean age 
of cases
Mean age 
of controls
Cases Controls
Null genotype
Adjusted OR
Cases Controls
Song 2006[9] China Hospital-based 49.05 47.22 130 130   77   57 NA
Zhou 2006[17] China Hospital-based 40.66 50.50 125 125   73   54 1.85(1.12-3.05)
Singh 2008[10] India Population-based 45.20 50.30 150 168   64   40 1.52(1.10-2.00)
Sobti 2006[18] India Hospital-based 48.60 48.00 103 103   42   38 NA
Niwa 2005[19] Japan Hospital-based 47.20 56.20 131 320   70 184 0.85(0.56-1.20)
Lee 2004[20] Korea Hospital-based NA NA   81   86   42   42 1.20(0.60-2.10)
Kim 2000[21] Korea Population-based 46.50 46.50 181 181   95   96 2.40(1.53-3.78)
Sharma 2004[22] India Hospital-based NA NA 142   96   81   33 2.50(1.40-4.50)
Chen 1999[23] America Hospital-based NA NA 190 206 101 118 0.80(0.60-1.30)
Joseph 2006[24] India Population-based 46.00 47.00 147 165   79  54 2.40(1.53- .78)
Palma 2010[11] Italy Population-based NA NA   81 111   49   58 1.93(0.96-3.88)
Nishino 2008[25] Japan Population-based 41.60 40.60 124 125   77   59 1.92(1.04-3.54)
Ueda 2008[26] Japan Population-based NA NA 144   54   75   28 NA
Settheetham-Ishida 2009[27] Thailand Population-based NA NA   69   72   54   56 0.62(0.30-2.03)
Agodi 2010[12] Italy Hospital-based NA NA   27 162   15   17 NA
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in Figure 1. Because of the heterogeneity among studies 
(PQ<0.001, I
2=74.5%), a random-effects model was used. The 
overall result showed that the association between GSTM1 
null genotype and risk for cervical cancer was statistically 
significant (OR=1.54, 95%CI=1.18-2.00). The adjusted pooled 
OR(95%CI) of GSTM1 null genotype for cervical cancer were 
1.14(0.95-1.32). No significant increased risk of cancer was 
observed, and also great heterogeneity was found between 
studies.
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Figure 1. Forest plot for the overall association between GSTM1 gene 
polymorphism and cervical cancer risk.
  Subgroup analysis was performed based on smoking and 
ethnicity (Figure 2 and 3). The result showed that smokers 
with null GSTM1 genotype had higher risk of cervical cancer 
(OR=1.56, 95%CI=1.01-2.41), while no significant increased 
risk was found in non-smokers. After stratification, the 
heterogeneity was significantly decreased (P=0.09 for 
non smokers and P=0.12 for smokers). For the ethnicity 
stratification, significant increased risk of null GSTM1 
genotype was found in Chinese (OR=1.85, 95%CI=1.30-2.63) 
and Indian population (OR=2.07, 95%CI=1.49-2.88), but no 
increased risk in other population. However, no significant 
decreased risk was found in American population.
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Figure 2. Relationship between GSTM1 gene polymorphism and 
cervical cancer risk by smoking status.
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Figure 3. Relationship between GSTM1 gene polymorphism and 
cervical cancer risk by ethnicity.
  Begg's funnel plot were generated to assess potential 
publication bias for GSTM1 (Figure 4), and the symmetry of 
the studies in the funnel plot showed no publication bias in 
this meta-analysis. The Egger's test showed no publication 
bias for GSTM1 (P value was 0.11). Moreover, the sensitivity 
analysis showed the robust of our meta-analysis after 
excluding an large sample size study[19].
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Figure 4. Funnel plot for GSTM1 gene polymorphism and cervical 
cancer risk.
4. Discussion
  Previously, genetic factors are considered as important 
factors in the development of cervical cancer. Previously, 
many studies investigated the association between GSTM1 
polymorphism and cervical cancer. However, the association 
between them is controversial. Some studies reported that 
the null genotypes are positively correlated, inversely 
correlated, or not correlated with with the risk for cervical 
cancer in different ethnic populations. These discrepancies 
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could have been due to limited sample numbers and ethnic 
differences. Therefore, we conducted a meta-analysis of 
15 published case-control studies to investigate the role 
of GSTM1 polymorphism in cervical cancer. The meta-
analysis result showed that the association between GSTM1 
null genotype and the risk for cervical cancer is statistically 
significant in smokers, and Chinese and Indian population 
but not in other populations.
  Many studies have reported the effect of ethnic differences 
on genetic predisposition to human diseases. For example, 
the incidence of cervical cancer is high in southern Africa, 
and is almost five-folds higher than in the Northern 
America and Australia[1]. It showed there were differences 
in ethnicities or in environment. In addition, the data 
showed that the allele frequency of GSTM1 null genotype 
was higher in American and Japanese than in Chinese 
and India populations. In the present study, we found that 
the association between GSTM1 null genotype and the risk 
of cervical cancer was statistically significant in Chinese 
and Indian but not in other populations. The reasons of the 
variation in the effect of the genotype might be the different 
of lifestyle, nutrition, environmental factors, and genetic 
factors in different ethnicities.
  The association between cervical cancer and cigarette 
smoking has been discussed since the late 1970s, and 
numerous studies represented by Winkelstein[28] and the 
IARC Multi-centre Cervical Cancer Study Group[29] have 
reported that the risk of developing cervical cancer was 
elevated two- to three-folds by smoking after adjusting for 
HPV infection status. Our study showed the cigarette could 
play an interaction role with null GSTM1 genotype, those 
smokers carrying the null genotype possessed increased 
susceptibility to cervical carcinogenesis.
  There are some limitations to this meta-analysis. Firstly, 
the sample size reported in the literature is still relatively 
small and might not provide sufficient power to estimate 
the association between the null GSTM1 polymorphism 
and cervical cancer risk. Secondly, it is widely recognized 
that environmental risk factors, such as exposure to HPV 
infection, cervical lesion type and genital health are major 
contributors to cervical cancer development. Understanding 
the interaction between environmental exposure and null 
GSTM1 polymorphism is an important priority; however, 
the lack of available data precludes examination of gene-
environment interactions in this meta-analysis. Our 
sensitivity analysis showed that the combined ORs did not 
change after the exclusion of studies with large sample size, 
suggesting that our results are methodologically robust. 
Begg's test also showed no evidence of potential publication 
bias, indicating that the preferential publication of positive 
results does not occur.
  In conclusion, this meta-analysis provide strong evidence 
that the GSTM1 null genotype is associated with the 
development of cervical cancer, and especially in Chinese 
and Indian population, and smokers showed a modification 
on the association between GSTM1 null genotype and 
cervical cancer. Well-designed and large sample studies 
should be performed to confirm this finding. Also, further 
studies investigating the effect of gene-environment 
interactions on cervical cancer risk are required.
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